Johnson & Johnson plans to start testing its investigational COVID-19 vaccine as soon as possible in young people aged 12 to 18, a business executive led by the U.S. Center for Disease Control and Prevention (CDC) on Friday said during ‘a meeting.
Dr de J&J. “We plan to get into the kids as soon as possible, but very carefully in terms of safety,” Jerry Sadoff said at a virtual meeting of the CDC’s advisory committee on immunization practices.
Based on safety and other factors, the company plans to test in young children as well, said Saddoff, vaccine research scientist at J & J.’s Jensen Unit.
J&J began testing the vaccine in adults in a phase III study of 60,000 volunteers at the end of September. Earlier this month, a participant had to stop the test due to a serious medical program. The study resumed last week.
Rival drugmaker Pfizer Inc. has already started testing the COVID-19 vaccine, which it is developing with BioNTech in children as young as 12 in Germany.
(Except for the title, this story was not edited by NDTV employees and posted from a syndicated feed.)